Pharmaceutical Impurity Reference Standards
Pharmaceutical impurity reference standards are highly purified compounds used as reference materials to identify, quantify, and characterize impurities in pharmaceutical products. These standards play a crucial role in pharmaceutical development, quality control, and regulatory compliance by providing a basis for assessing the purity, safety, and efficacy of drug substances and formulations. Impurities in pharmaceuticals can arise from various sources including raw materials, synthesis processes, degradation over time, or interactions with packaging materials. Pharmaceutical companies and regulatory agencies use impurity reference standards to validate analytical methods, establish acceptance criteria for impurity levels, and ensure that drug products meet stringent quality standards.
- Structure
- Product name
- CAS No.
- Molecular formula
- Inquiry
-
-
(2S,20S,21S,22R,23R,24R,25S,26R,27S)-6,21,23-trihydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-11-methylene-1,5,15-trioxo-1,2,5,11-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)furo[2'',3'':7',8']naphtho[1',2':4,5]imidazo[1,2-a]pyridin-25-yl acetate
- 1351775-04-6
- C43H49N3O11
- inquiry